Craig-Hallum Upgrades CareDx to Buy, Raises Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
Craig-Hallum analyst Alexander Nowak upgrades CareDx (NASDAQ:CDNA) from Hold to Buy and raises the price target from $12 to $15.

May 01, 2024 | 5:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CareDx upgraded to Buy from Hold by Craig-Hallum, with a price target increase from $12 to $15.
The upgrade by Craig-Hallum from Hold to Buy, accompanied by a price target increase, is a strong positive signal for CareDx. This suggests increased confidence in the company's future performance and is likely to influence investor sentiment positively, potentially leading to a short-term increase in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100